相关实验视频

Updated: May 5, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

心血管疾病中的巨细胞分裂:机制和治疗含义

Neha Gupta^1,2, Yu Liu^1,2, Bishuang Cai^1,2

¹Vatche and Tamar Manoukian Division of Digestive Diseases, Department of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

|March 3, 2026

概括

有效的血细胞分裂,即心脏巨细胞清除死细胞,对于解决炎症和改善心血管疾病 (CVD) 的结果至关重要. 功能受损的乙细胞增生使炎症延续,并阻碍恢复,突显了其治疗潜力.

科学领域:

心血管生物学心血管生物学
免疫学免疫学免疫学
细胞平衡是细胞的平衡.

背景情况:

心血管疾病 (CVD) 在全球造成数百万人的死亡,而炎症在它们的发病过程中发挥着关键作用.
失调的炎症加速疾病的进展,并破坏细胞平衡,导致不良的临床结果.
有效地解决炎症和恢复组织完整性对于管理心血管疾病至关重要.

研究的目的:

在心血管健康的背景下,审查当前对巨细胞衰变的理解.
探索埃弗洛细胞形成的分子机制及其在解决心脏炎症中的作用.
突出提高对治疗心血管疾病的治疗效果的治疗潜力.

主要方法:

这篇小小的综述巩固了现有的关于巨细胞衰变的研究.
它检查了涉及到心脏巨细胞对亡细胞清除的分子机制.
该综述综合了关于细胞效率与心血管疾病结果之间的关联的研究结果.

主要成果:

通过心脏巨细胞的高效效能细胞分解对于解决炎症和恢复组织平衡至关重要.
功能受损的血细胞增生使炎症延续,加剧心血管疾病的进展,并阻碍恢复.
成功的细胞增生抑制了促炎性细胞因子,并促进了抗炎性反应.

结论:

巨细胞增生是心血管健康中被低估但至关重要的过程.
增强乙细胞形成是一种有前途的治疗策略,用于管理和治疗心血管疾病.
进一步研究血细胞分裂机制可以为心血管疾病干预开辟新的途径.

关键词:

动脉样硬化动脉样硬化心血管疾病心血管疾病发生了细胞化 (efferocytosis).巨细胞是什么?巨细胞是什么?

更多相关视频

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

In Vivo Assessment of Alveolar Macrophage Efferocytosis Following Ozone Exposure

Published on: October 22, 2019

相关概念视频

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Inflammation

Inflammation

Phagocytosis of Apoptotic Cells

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...